This inventor holds 1 USPTO granted patent. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997
Title: Shigeru Owada: Innovator in Pharmaceutical Research
Introduction
Shigeru Owada is a notable inventor based in Musashino, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have therapeutic applications. His work is recognized for its potential impact on medical treatments.
Latest Patents
Owada holds a patent for "Carbostyril derivatives for inhibiting production of interleukin-8." This innovation is crucial in the context of inflammatory diseases, as interleukin-8 plays a significant role in the inflammatory response. His patent portfolio includes 1 patent that showcases his expertise in medicinal chemistry.
Career Highlights
Shigeru Owada is affiliated with Otsuka Pharmaceutical Company, Limited, where he has been instrumental in advancing research initiatives. His role at Otsuka has allowed him to collaborate with other talented professionals in the field, contributing to the company's reputation for innovation.
Collaborations
Owada has worked alongside notable colleagues such as Takahide Matsuda and Miki Aihara. These collaborations have fostered a dynamic research environment, leading to advancements in pharmaceutical science.
Conclusion
Shigeru Owada's contributions to pharmaceutical research and his innovative patent demonstrate his commitment to improving healthcare solutions. His work continues to influence the development of new therapies that can benefit patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile